Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $28.27. The company's market cap stands at 161.13B, with a P/E ratio of 37.45 and a dividend yield of 6.08%.
During the trading session on 2026-10-10, Pfizer(PFE) shares reached a daily high of $28.29 and a low of $27.59. At a current price of $28.27, the stock is +2.5% higher than the low and still -0.1% under the high.
Trading activity shows a volume of 23.2M, compared to an average daily volume of 31.33M.
The stock's 52-week range extends from a low of $23.62 to a high of $29.21.
The stock's 52-week range extends from a low of $23.62 to a high of $29.21.
PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. (PFE) is accelerating its late-stage pip...
Six dividend stocks in a $500,000 portfolio sound like a solid income plan, but where you hold them decides how much of that income you actually keep, and the d...
...
Analyst ratings
59%
of 29 ratingsMore PFE News
A nationwide initiative to accelerate personalized cancer vaccine development is drawing fresh investor interest in vaccine makers, sending several biotechnolog...
Investing Pfizer’s Dividend Yield Is Above 6%. Wall Street May Be Sending a Warning Pfizer's dividend yield has climbed well above what most blue-chip drugmaker...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase 3 study called “AN INTERVENTIONAL PHASE 3 STUDY TO E...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. is running a Phase 3 study called “A Study to Learn About the Study Medicine...
Investing Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock trades at $207.80,...
JPMorgan raised the firm’s price target on Pfizer (PFE) to $30 from $28 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate sour...
Investing Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.